Afghanistan Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia and Herzegowina Botswana Bouvet Island Brazil British Indian Ocean Territory Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Cook Islands Costa Rica Cote D'Ivoire Croatia Cuba Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic East Timor Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands (Malvinas) Faroe Islands Fiji Finland France France, Metropolitan French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guinea Guinea-bissau Guyana Haiti Heard and Mc Donald Islands Honduras Hong Kong Hungary Iceland India Indonesia Iran (Islamic Republic of) Iraq Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Kiribati Korea, Democratic People's Republic of Korea, Republic of Kuwait Kyrgyzstan Lao People's Democratic Republic Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macau Macedonia, The Former Yugoslav Republic of Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia, Federated States of Moldova, Republic of Monaco Mongolia Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands Netherlands Antilles New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island Northern Mariana Islands Norway Oman Pakistan Palau Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Reunion Romania Russian Federation Rwanda Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Seychelles Sierra Leone Singapore Slovakia (Slovak Republic) Slovenia Solomon Islands Somalia South Africa South Georgia and the South Sandwich Islands Spain Sri Lanka St. Helena St. Pierre and Miquelon Sudan Suriname Svalbard and Jan Mayen Islands Swaziland Sweden Switzerland Syrian Arab Republic Taiwan Tajikistan Tanzania, United Republic of Thailand Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States United States Minor Outlying Islands Uruguay Uzbekistan Vanuatu Vatican City State (Holy See) Venezuela Viet Nam Virgin Islands (British) Virgin Islands (U.S.) Wallis and Futuna Islands Western Sahara Yemen Yugoslavia Zaire Zambia Zimbabwe
Ingredients & Description
Celadrin® is a unique formulation of esterified (stable) fatty acids that can also be an effective option for topical joint pain relief. Studies have confirmed the benefits of topical applications of the cream directly to sore joints. When applied topically, Celadrin is well-absorbed and can act locally to help maintain joint comfort and increase the range of motion of joints.
Researchers have found significant improvement with the use of Celadrin® Cream. Overall, there has been reported significant improvement in joint range of motion, comfort levels, muscular endurance and joint function from topical application of Celadrin® Cream.
Improved Range of Motion*
Relief from Pain and Discomfort*
Increased Endurance *
Menthol (1.25%) Topical Analgesic
Celadrin Proprietary Blend (blend of esterified fatty acid carbons (EFAC) including Cetyl Myristate, Cetyl Myristoleate, Cetyl Oleate, Cetyl Palmitoleate, Cetyl Laurate), Benzyl Alcohol, Glycerin, Glyceryl Stearate, Mentha Piperita (Peppermint Oil), Olea Europaea (Olive) Fruit Oil, PEG 100 Stearate, Cetyl Alcohol, Phenoxyethanol, Chlorphenesin, Benzoic Acid, Butylene, Glycol, Sorbic Acid, Cetearyl Alcohol, Carbomer, Alpha Tocopherol Acetate(Vitamin E), Lecithin, Potassium Hydroxide.
Suggested Use: Adults and children 2 years of age and older. Apply to affected area not more than 3 to 4 times per day.
For external use only.
Avoid contact with eyes.
If condition worsens, or if symptoms persist for more than 7 days or clear up and occur again within a few days, discontinue use of product and consult a physician.
Do not apply to wounds or damaged skin.
Do not bandage tightly.
Keep out of reach of children.
If swallowed, get medical help or contact a poison control center immediately.
Store in a cool, dry place.
*These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease.
Distributed or manufactured from Doctor's Best. See more
*Not intended to diagnose or treat diseases or ailments, and is not reviewed by the
Uses & Indications.
Relief From Joint Pain And Discomfort
Ailments & Concerns.
Discomfort From Aging And Worn Joints
Sore And Swollen Joints
Questions and answers: